Research Open Terminal →
VRTX

Vertex Pharmaceuticals

XNAS · PHARMACEUTICAL PREPARATIONS

12 articles20 insider tx20 holders0 supply chain10 selling intent filings2 new insiders

Financials

SEC XBRL company-facts figures. Quarterly and annual periods are shown separately and are not mixed with year-to-date totals. Click a figure for the filing it came from.

Latest quarter at a glance

Q3'26

Contract revenue, excluding tax

$3.4B
Exact value
$3,440,800,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

YoY 11.8%

Operating income (GAAP)

$712.9M
Exact value
$712,900,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

YoY -39.9%

Net income

$653.6Mattributable to parent
Exact value
$653,600,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

YoY -39.6%

Diluted EPS

$2.56
Exact value
$2.56 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

YoY -39.0%

Quarterly

Data through quarter ended September 30, 2026 · Source filing date: November 3, 2026

$0B$1B$2B$3BQ2'24 $2,645,600,000 USD$2,645,600,000 USDQ3'24 $2,771,900,000 USD$2,771,900,000 USDQ1'25 $2,770,200,000 USD$2,770,200,000 USDQ2'25 $2,964,700,000 USD$2,964,700,000 USDQ3'25 $3,076,400,000 USD$3,076,400,000 USDQ1'26 $2,986,900,000 USD$2,986,900,000 USDQ2'26 $3,333,900,000 USD$3,333,900,000 USDQ3'26 $3,440,800,000 USD$3,440,800,000 USDQ2'24Q3'24Q1'25Q2'25Q3'25Q1'26Q2'26Q3'26
Revenue
PeriodValue
Q2'24$2,645,600,000 USD
Q3'24$2,771,900,000 USD
Q1'25$2,770,200,000 USD
Q2'25$2,964,700,000 USD
Q3'25$3,076,400,000 USD
Q1'26$2,986,900,000 USD
Q2'26$3,333,900,000 USD
Q3'26$3,440,800,000 USD

Contract revenue, excluding tax

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$3.4B
Exact value
$3,440,800,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index
$3.1B11.8%
Q2'26 · quarter ended 2026-06-30
$3.3B
Exact value
$3,333,900,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2026-04-01 to 2026-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index
$3B12.5%
Q1'26 · quarter ended 2026-03-31
$3B
Exact value
$2,986,900,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2026-01-01 to 2026-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index
$2.8B7.8%
Q3'25 · quarter ended 2025-09-30
$3.1B
Exact value
$3,076,400,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2025-07-01 to 2025-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000232 10-Q filed 2025-11-04
$2.8B11.0%
Q2'25 · quarter ended 2025-06-30
$3B
Exact value
$2,964,700,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2025-04-01 to 2025-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000216 10-Q filed 2025-08-05
$2.6B12.1%
Q1'25 · quarter ended 2025-03-31
$2.8B
Exact value
$2,770,200,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2025-01-01 to 2025-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000192 10-Q filed 2025-05-06
$2.7B3.0%
Q3'24 · quarter ended 2024-09-30
$2.8B
Exact value
$2,771,900,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2024-07-01 to 2024-09-30
Accession
0000875320-25-000232
Form
10-Q
Filed
2025-11-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000223 10-Q filed 2024-11-05
$2.5B11.6%
Q2'24 · quarter ended 2024-06-30
$2.6B
Exact value
$2,645,600,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2024-04-01 to 2024-06-30
Accession
0000875320-25-000216
Form
10-Q
Filed
2025-08-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000198 10-Q filed 2024-08-02
$2.5B6.1%

Operating income (GAAP)

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$712.9M
Exact value
$712,900,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index
$1.2B-39.9%
Q2'26 · quarter ended 2026-06-30
$1.2B
Exact value
$1,246,900,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-04-01 to 2026-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index
$1.2B8.3%
Q1'26 · quarter ended 2026-03-31
$1.1B
Exact value
$1,138,100,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2026-01-01 to 2026-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index
$630.1M80.6%
Q3'25 · quarter ended 2025-09-30
$1.2B
Exact value
$1,186,200,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-07-01 to 2025-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000232 10-Q filed 2025-11-04
$1.1B6.3%
Q2'25 · quarter ended 2025-06-30
$1.2B
Exact value
$1,151,100,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-04-01 to 2025-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000216 10-Q filed 2025-08-05
-$3.5Bn/m
Q1'25 · quarter ended 2025-03-31
$630.1M
Exact value
$630,100,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-01-01 to 2025-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000192 10-Q filed 2025-05-06
$1.1B-44.7%
Q3'24 · quarter ended 2024-09-30
$1.1B
Exact value
$1,116,300,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2024-07-01 to 2024-09-30
Accession
0000875320-25-000232
Form
10-Q
Filed
2025-11-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000223 10-Q filed 2024-11-05
$1B7.5%
Q2'24 · quarter ended 2024-06-30
-$3.5B
Exact value
-$3,514,700,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2024-04-01 to 2024-06-30
Accession
0000875320-25-000216
Form
10-Q
Filed
2025-08-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000198 10-Q filed 2024-08-02
$1Bn/m

Net income

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$653.6Mattributable to parent
Exact value
$653,600,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index
$1.1B-39.6%
Q2'26 · quarter ended 2026-06-30
$1.1Battributable to parent
Exact value
$1,099,800,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-04-01 to 2026-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index
$1B6.5%
Q1'26 · quarter ended 2026-03-31
$1Battributable to parent
Exact value
$1,031,400,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2026-01-01 to 2026-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index
$646.3M59.6%
Q3'25 · quarter ended 2025-09-30
$1.1Battributable to parent
Exact value
$1,082,900,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-07-01 to 2025-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000232 10-Q filed 2025-11-04
$1B3.6%
Q2'25 · quarter ended 2025-06-30
$1Battributable to parent
Exact value
$1,032,900,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-04-01 to 2025-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000216 10-Q filed 2025-08-05
-$3.6Bn/m
Q1'25 · quarter ended 2025-03-31
$646.3Mattributable to parent
Exact value
$646,300,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-01-01 to 2025-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000192 10-Q filed 2025-05-06
$1.1B-41.2%
Q3'24 · quarter ended 2024-09-30
$1Battributable to parent
Exact value
$1,045,400,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2024-07-01 to 2024-09-30
Accession
0000875320-25-000232
Form
10-Q
Filed
2025-11-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000223 10-Q filed 2024-11-05
$1B1.0%
Q2'24 · quarter ended 2024-06-30
-$3.6Battributable to parent
Exact value
-$3,593,600,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2024-04-01 to 2024-06-30
Accession
0000875320-25-000216
Form
10-Q
Filed
2025-08-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000198 10-Q filed 2024-08-02
$915.7Mn/m

Diluted EPS

PeriodValuePriorYoY
Q3'26 · quarter ended 2026-09-30
$2.56
Exact value
$2.56 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-07-01 to 2026-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index
$4.20-39.0%
Q2'26 · quarter ended 2026-06-30
$4.31
Exact value
$4.31 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-04-01 to 2026-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index
$3.998.0%
Q1'26 · quarter ended 2026-03-31
$4.02
Exact value
$4.02 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2026-01-01 to 2026-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index
$2.4961.4%
Q3'25 · quarter ended 2025-09-30
$4.20
Exact value
$4.20 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-07-01 to 2025-09-30
Accession
0000875320-26-000291
Form
10-Q
Filed
2026-11-03
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000232 10-Q filed 2025-11-04
$4.014.7%
Q2'25 · quarter ended 2025-06-30
$3.99
Exact value
$3.99 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-04-01 to 2025-06-30
Accession
0000875320-26-000259
Form
10-Q
Filed
2026-08-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000216 10-Q filed 2025-08-05
-$13.92n/m
Q1'25 · quarter ended 2025-03-31
$2.49
Exact value
$2.49 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-01-01 to 2025-03-31
Accession
0000875320-26-000173
Form
10-Q
Filed
2026-05-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000192 10-Q filed 2025-05-06
$4.21-40.9%
Q3'24 · quarter ended 2024-09-30
$4.01
Exact value
$4.01 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2024-07-01 to 2024-09-30
Accession
0000875320-25-000232
Form
10-Q
Filed
2025-11-04
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000223 10-Q filed 2024-11-05
$3.971.0%
Q2'24 · quarter ended 2024-06-30
-$13.92
Exact value
-$13.92 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2024-04-01 to 2024-06-30
Accession
0000875320-25-000216
Form
10-Q
Filed
2025-08-05
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000198 10-Q filed 2024-08-02
$3.52n/m

Annual

Data through fiscal year ended December 31, 2025 · Source filing date: February 13, 2026

$0B$5B$10BFY20 $6,205,700,000 USD$6,205,700,000 USDFY21 $7,574,400,000 USD$7,574,400,000 USDFY22 $8,930,700,000 USD$8,930,700,000 USDFY23 $9,869,200,000 USD$9,869,200,000 USDFY24 $11,020,100,000 USD$11,020,100,000 USDFY25 $12,001,300,000 USD$12,001,300,000 USDFY20FY21FY22FY23FY24FY25
Revenue
PeriodValue
FY20$6,205,700,000 USD
FY21$7,574,400,000 USD
FY22$8,930,700,000 USD
FY23$9,869,200,000 USD
FY24$11,020,100,000 USD
FY25$12,001,300,000 USD

Contract revenue, excluding tax

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$12B
Exact value
$12,001,300,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2025-01-01 to 2025-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index
$11B8.9%
FY24 · year ended 2024-12-31
$11B
Exact value
$11,020,100,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2024-01-01 to 2024-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
$9.9B11.7%
FY23 · year ended 2023-12-31
$9.9B
Exact value
$9,869,200,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2023-01-01 to 2023-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000062 10-K filed 2024-02-15
  • 0000875320-25-000053 10-K filed 2025-02-13
$8.9B10.5%
FY22 · year ended 2022-12-31
$8.9B
Exact value
$8,930,700,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2022-01-01 to 2022-12-31
Accession
0000875320-25-000053
Form
10-K
Filed
2025-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-23-000007 10-K filed 2023-02-10
  • 0000875320-24-000062 10-K filed 2024-02-15
$7.6B17.9%
FY21 · year ended 2021-12-31
$7.6B
Exact value
$7,574,400,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2021-01-01 to 2021-12-31
Accession
0000875320-24-000062
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-22-000007 10-K filed 2022-02-09
  • 0000875320-23-000007 10-K filed 2023-02-10
——
FY20 · year ended 2020-12-31
$6.2B
Exact value
$6,205,700,000 USD
Metric
Revenue
Scope
consolidated
XBRL concept
RevenueFromContractWithCustomerExcludingAssessedTax
Period
2020-01-01 to 2020-12-31
Accession
0000875320-23-000007
Form
10-K
Filed
2023-02-10
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-21-000006 10-K filed 2021-02-11
  • 0000875320-22-000007 10-K filed 2022-02-09
——

Operating income (GAAP)

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$4.2B
Exact value
$4,173,300,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2025-01-01 to 2025-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index
-$232.9Mn/m
FY24 · year ended 2024-12-31
-$232.9M
Exact value
-$232,900,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2024-01-01 to 2024-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
$3.8Bn/m
FY23 · year ended 2023-12-31
$3.8B
Exact value
$3,832,000,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2023-01-01 to 2023-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
  • 0000875320-24-000062 10-K filed 2024-02-15
$4.3B-11.0%
FY22 · year ended 2022-12-31
$4.3B
Exact value
$4,307,400,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2022-01-01 to 2022-12-31
Accession
0000875320-25-000053
Form
10-K
Filed
2025-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000062 10-K filed 2024-02-15
  • 0000875320-23-000007 10-K filed 2023-02-10
$2.8B54.8%
FY21 · year ended 2021-12-31
$2.8B
Exact value
$2,782,100,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2021-01-01 to 2021-12-31
Accession
0000875320-24-000062
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-23-000007 10-K filed 2023-02-10
  • 0000875320-22-000007 10-K filed 2022-02-09
——
FY20 · year ended 2020-12-31
$2.9B
Exact value
$2,856,300,000 USD
Metric
Operating income (GAAP)
Scope
GAAP, consolidated
XBRL concept
OperatingIncomeLoss
Period
2020-01-01 to 2020-12-31
Accession
0000875320-23-000007
Form
10-K
Filed
2023-02-10
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-22-000007 10-K filed 2022-02-09
  • 0000875320-21-000006 10-K filed 2021-02-11
——

Net income

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$4Battributable to parent
Exact value
$3,953,200,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2025-01-01 to 2025-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index
-$535.6Mn/m
FY24 · year ended 2024-12-31
-$535.6Mattributable to parent
Exact value
-$535,600,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2024-01-01 to 2024-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
$3.6Bn/m
FY23 · year ended 2023-12-31
$3.6Battributable to parent
Exact value
$3,619,600,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2023-01-01 to 2023-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
  • 0000875320-24-000062 10-K filed 2024-02-15
$3.3B9.0%
FY22 · year ended 2022-12-31
$3.3Battributable to parent
Exact value
$3,322,000,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2022-01-01 to 2022-12-31
Accession
0000875320-25-000053
Form
10-K
Filed
2025-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000062 10-K filed 2024-02-15
  • 0000875320-23-000007 10-K filed 2023-02-10
$2.3B41.8%
FY21 · year ended 2021-12-31
$2.3Battributable to parent
Exact value
$2,342,100,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2021-01-01 to 2021-12-31
Accession
0000875320-24-000062
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-23-000007 10-K filed 2023-02-10
  • 0000875320-22-000007 10-K filed 2022-02-09
——
FY20 · year ended 2020-12-31
$2.7Battributable to parent
Exact value
$2,711,700,000 USD
Metric
Net income
Scope
attributable to parent
XBRL concept
NetIncomeLoss
Period
2020-01-01 to 2020-12-31
Accession
0000875320-23-000007
Form
10-K
Filed
2023-02-10
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-22-000007 10-K filed 2022-02-09
  • 0000875320-21-000006 10-K filed 2021-02-11
——

Diluted EPS

PeriodValuePriorYoY
FY25 · year ended 2025-12-31
$15.32
Exact value
$15.32 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2025-01-01 to 2025-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index
-$2.08n/m
FY24 · year ended 2024-12-31
-$2.08
Exact value
-$2.08 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2024-01-01 to 2024-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
$13.89n/m
FY23 · year ended 2023-12-31
$13.89
Exact value
$13.89 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2023-01-01 to 2023-12-31
Accession
0000875320-26-000056
Form
10-K
Filed
2026-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-25-000053 10-K filed 2025-02-13
  • 0000875320-24-000062 10-K filed 2024-02-15
$12.828.3%
FY22 · year ended 2022-12-31
$12.82
Exact value
$12.82 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2022-01-01 to 2022-12-31
Accession
0000875320-25-000053
Form
10-K
Filed
2025-02-13
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-24-000062 10-K filed 2024-02-15
  • 0000875320-23-000007 10-K filed 2023-02-10
$9.0142.3%
FY21 · year ended 2021-12-31
$9.01
Exact value
$9.01 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2021-01-01 to 2021-12-31
Accession
0000875320-24-000062
Form
10-K
Filed
2024-02-15
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-23-000007 10-K filed 2023-02-10
  • 0000875320-22-000007 10-K filed 2022-02-09
$10.29-12.4%
FY20 · year ended 2020-12-31
$10.29
Exact value
$10.29 per share
Metric
Diluted EPS
Scope
diluted
XBRL concept
EarningsPerShareDiluted
Period
2020-01-01 to 2020-12-31
Accession
0000875320-23-000007
Form
10-K
Filed
2023-02-10
Derivation
direct
Filing
SEC filing index

Other filings for this period

  • 0000875320-22-000007 10-K filed 2022-02-09
  • 0000875320-21-000006 10-K filed 2021-02-11
——

Research articles

Includes notes from domestic 8-K and foreign private issuer 6-K disclosures.

View all articles →

Recent insider activity

Insider net $ (monthly)open-market Form 4 only - grants, exercises, tax withholding excluded$100.0M$50.0M$0-$50.0M-$100.0M2024-10 -$461K2024-11 -$9.4M2024-12 $02025-01 $02025-02 -$8.8M2025-03 -$10.1M2025-04 $02025-05 -$224K2025-06 $02025-07 $02025-08 $5.7M2025-09 $02025-10 -$281K2025-11 -$33.4M2025-12 -$34.0M2026-01 -$6.5M2026-02 -$64.4M2026-03 -$5.1M2026-04 -$439K2026-05 -$5.3M2026-06 -$3.7M2026-07 -$2.0M2026-08 $02026-09 $02026-10 $02026-11 -$14.7MInstitutional shares (majority-gated quarters)100.0M50.0M02025-Q4 74.9M sh2026-Q1 52.7M sh2026-Q2 52.6M shOct 24Dec 24Feb 25Apr 25Jun 25Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26Oct 26Q4 2025Q1 2026Q2 2026~ derived from SEC-reported shares x price. Hatched: excluded (implausible price) or unpriced.

open-market Form 4 only - grants, exercises, tax withholding excluded

0 buyers - 2 unique sellers · 6 accumulating - 7 trimming - 1 unchanged

Date Insider Title Type Shares Price Value
November 12, 2026 Wagner Charles F Jr EVP, CO & FO SELL -15,286 $548 ~$8.4M
November 6, 2026 Kewalramani Reshma CEO & President SELL -11,866 $532 ~$6.3M
October 20, 2026 Brennan Daniel J. — GRANT 795 $503 ~$0.4M
October 15, 2026 Garber Alan M — GRANT 29.27 $512 ~$15K
October 15, 2026 Sachs Bruce I — GRANT 92.69 $512 ~$48K
September 8, 2026 van Grunsven Jasper EVP, CP and NPPO GRANT 8,682 — —
August 28, 2026 Ambrose Kristen SVP & Chief Accounting Officer GRANT 5,000 — —
August 27, 2026 Sachs Bruce I — GIFT -6,000 — —
July 21, 2026 Tatsis Ourania EVP, Chief Reg. & Quality Off. GRANT 8,251 — —
July 21, 2026 Sachdev Amit EVP Chief Patient & Ext Af Off GRANT 8,251 — —
July 15, 2026 Sachs Bruce I — GRANT 99.94 $475 ~$47K
July 15, 2026 Garber Alan M — GRANT 31.56 $475 ~$15K
July 2, 2026 Tatsis Ourania EVP, Chief Reg. & Quality Off. SELL -1,500 $525 ~$0.8M
July 2, 2026 McKechnie Duncan EVP, Chief Commercial Officer SELL -1,541 $519 ~$0.8M
July 1, 2026 Liu Joy EVP and Chief Legal Officer SELL -828 $503 ~$0.4M
June 26, 2026 Bozic Carmen EVP and CMO SELL -596 $483 ~$0.3M
June 18, 2026 Bozic Carmen EVP and CMO SELL -1,020 $462 ~$0.5M
June 15, 2026 Bozic Carmen EVP and CMO SELL -4,062 $450 ~$1.8M
June 5, 2026 Bozic Carmen EVP and CMO SELL -1,745 $450 ~$0.8M
June 1, 2026 Liu Joy EVP and Chief Legal Officer SELL -828 $440 ~$0.4M

Insider Selling Intent (Form 144)

Date Filer Relationship Est. shares Filing
November 16, 2026 Thornberry Nancy — 1,000 SEC
November 16, 2026 Bhatia Sangeeta N. — 271 SEC
November 12, 2026 Wagner Charles F Jr — 15,286 SEC
November 6, 2026 Kewalramani Reshma — 11,866 SEC
August 27, 2026 Bruce I. Sachs — — SEC
July 2, 2026 Tatsis Ourania — 1,500 SEC
July 2, 2026 McKechnie Duncan — 1,541 SEC
July 1, 2026 Liu Joy — 828 SEC
June 26, 2026 Bozic Carmen — 596 SEC
June 18, 2026 Bozic Carmen — 1,020 SEC

New Insiders (Form 3)

Date Insider Title Relationship Shares Filing
October 22, 2026 Brennan Daniel J. — — — SEC
September 10, 2026 — — — — SEC

Institutional holdings

Institution Shares Value ($) Change % Filing date
BlackRock 24,109,373 ~$12.0B 0.6% August 7, 2026
Vanguard Group 24,105,823 ~$10.9B prior history unverified January 29, 2026
BlackRock 23,751,989 ~$10.8B prior history unverified February 12, 2026
BlackRock 23,969,517 ~$10.7B 0.9% May 13, 2026
BlackRock 21,312,244 ~$10.0B prior history unverified August 13, 2024
State Street 11,871,459 ~$5.9B 1.2% August 7, 2026
State Street 11,689,539 ~$5.3B prior history unverified February 13, 2026
State Street 11,730,139 ~$5.2B 0.3% May 15, 2026
JP Morgan Chase 6,674,600 ~$3.3B -7.5% August 12, 2026
JP Morgan Chase 7,219,956 ~$3.2B 17.6% May 13, 2026
JP Morgan Chase 6,141,281 ~$2.8B prior history unverified February 11, 2026
Morgan Stanley 3,242,139 ~$1.6B 1.7% August 13, 2026
Morgan Stanley 3,188,881 ~$1.4B 2.2% May 15, 2026
Morgan Stanley 3,120,310 ~$1.4B prior history unverified May 27, 2026
Goldman Sachs 2,531,961 ~$1.3B 2.6% August 14, 2026
Goldman Sachs 2,466,575 ~$1.1B 36.1% May 15, 2026
Fidelity (FMR) 2,212,596 ~$1.0B prior history unverified February 17, 2026
Fidelity (FMR) 2,020,265 ~$902.1M -8.7% May 15, 2026
Goldman Sachs 1,812,218 ~$821.6M prior history unverified March 25, 2026
Fidelity (FMR) 1,457,158 ~$723.8M -27.9% August 13, 2026
Want deeper analysis?
Investabot monitors SEC filings daily and generates institutional-grade research on insider trades, risk factors, supply chains, and more.
Open the Terminal — Free →